CAPSTONE INVESTMENT ADVISORS, LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$40,508,000
-55.2%
342,100
-55.4%
0.12%
-60.7%
Q4 2020$90,506,000
+62.8%
766,288
+53.2%
0.30%
+6.7%
Q3 2020$55,594,000500,2160.28%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 149,457$11,773,0006.29%
INDUS CAPITAL PARTNERS, LLC 330,339$26,021,0002.54%
Perpetual Ltd 129,799$10,215,0001.32%
Black Creek Investment Management Inc. 396,525$31,234,0001.18%
RUDMAN ERROL M 28,701$2,261,0001.10%
COMGEST GLOBAL INVESTORS S.A.S. 635,752$50,078,0001.09%
Antipodean Advisors LLC 15,000$1,182,0000.96%
Hillhouse Capital Management 618,391$48,711,0000.83%
JUPITER ASSET MANAGEMENT LTD 215,866$17,004,0000.49%
Temasek Holdings (Private) Ltd 990,000$77,982,0000.48%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders